Nicotine
Nicotine is a naturally occurring alkaloid found primarily in tobacco and in trace amounts in plants such as tomatoes and aubergines.citation needed It acts as a stimulant at low doses, promoting the release of dopamine, serotonin, and adrenaline, while higher doses produce calming and muscle-relaxing effects. Widely regarded as one of the most addictive substances known,1 it is used both recreationally through tobacco products and therapeutically as a smoking cessation aid.citation needed
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
An average cigarette delivers approximately 2 mg of absorbed nicotine, a reinforcing dose that remains far below toxic levels.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Effects vary widely by individual, dose, and context.
Physical
Cognitive
Pharmacology
Pharmacodynamics
Nicotine acts as an agonist at most subtypes of nicotinic acetylcholine receptors (nAChRs), with particularly high affinity at the α4β2 subtype (Ki = 1 nM)citation needed, while functioning as an antagonist at the α9 and α10 subtypes.2 Activation of central nAChRs stimulates the release of multiple neurotransmitters including dopamine, norepinephrine, acetylcholine, and serotonin.citation needed Binding at α4β2 receptors on dopaminergic neurons within the mesolimbic pathway drives dopamine release, which underlies the substance's reinforcing properties. Nicotine also acts on nicotinic receptors in the adrenal medulla, triggering the release of epinephrine and norepinephrine into the bloodstream through calcium-dependent exocytosis. The naturally occurring (S)-enantiomer is 4 to 28 times more potent than (R)-nicotine in standard binding and functional assays.
Pharmacokinetics
Nicotine distributes rapidly through the bloodstream and crosses the blood-brain barrier within 10 to 20 seconds of inhalation.citation needed It is primarily metabolized in the liver by CYP2A6, with additional contributions from CYP2B6 and FMO3 (the latter selectively metabolizing the (S)-enantiomer). The major metabolite is cotinine, which is pharmacologically active and persists in the blood with a half-life of 15 to 20 hours. Nicotine itself has an elimination half-life of approximately 1 to 3 hours. Absorption is modulated by the molecule's ionization state, which is governed by pH relative to its pKa values.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Other nicotinic acetylcholine receptor agonists
Harm Potential
Addiction & Dependence
Psychological
Extremely HighNicotine is consistently described as one of the most addictive drugs in existence.citation needed It activates the mesolimbic reward pathway and induces long-term ΔFosB expression in the nucleus accumbens, resulting in strong psychological dependence. Discontinuation produces affective withdrawal symptoms including anxiety, irritability, intense craving, and anhedonia.
Physical
HighNicotine produces significant physical dependence with chronic use. Withdrawal symptoms include somatic effects such as mild motor dysfunction and tremor, alongside depression, restlessness, insomnia, and in the long-term with abstinence, weight gain.citation needed Withdrawal symptoms peak within one to three days and can persist for several weeks, though withdrawal is not life-threatening.
Toxicity
Acute use causes transient increases in heart rate, blood pressure, and systemic vasoconstriction including coronary arteries;citation needed long-term exposure may impair endothelial function and potentially contribute to atherosclerosis, with cardiac arrhythmias primarily a concern in individuals with underlying heart disease. Short-term nicotine use in healthy individuals poses little cardiovascular risk.
Heavy chronic use is associated with less efficient brain network architecture and disruptions in topological organization of brain networks; adolescent exposure may impair neurodevelopment up to age twenty-five,citation needed and some research suggests potential damage to medial habenula neurons regulating nicotine avoidance behaviors in chronic users.
Nicotine is considered a possible teratogen in humans; it crosses the placenta and negatively affects fetal brain development, with prenatal exposure associated with lower birth weight, increased risk of miscarriage and stillbirth, and potential long-term metabolic and neurobehavioral consequences in offspring.citation needed
Chronic exposure suppresses both innate and adaptive immune responses, downregulating cell-mediated immunity against infections and potentially reducing immune surveillance against neoplastic diseases.citation needed
May promote and aggravate periodontal diseases including periodontitis and gingivitis, particularly in the presence of harmful oral microorganisms.
Seizure Risk
Seizures are documented only at toxic or overdose-level doses and do not occur at typical recreational or therapeutic doses. Lethal nicotine poisoning rapidly produces seizures, and death from respiratory paralysis may occur within minutes of a severe overdose.citation needed
History & Culture
Introduction to Europe
Tobacco first arrived in Europe during the early 1530s, brought back by Spanish explorers from the Americas. The plant quickly gained a reputation as a medicinal wonder, with smoking believed to offer protection against various illnesses, including the plague. This perception of tobacco as a "holy…
Legality
By Country
References
Source Pages
Citations
- Aslam SP, Leslie SW, & Morris J. (2024). Nicotine Addiction and Smoking: Health Effects and Interventions. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK537066/1
- Nicotine: Biological activity. IUPHAR/BPS Guide to Pharmacology (n.d.). https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=25851
- Effect of Nicotine on Immune System Function. Biomolecules (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC9871277/12
- McIndoo NE. (1943). Insecticidal Uses of Nicotine and Tobacco: A Condensed Summary of the Literature, 1690-1934. United States Department of Agriculture, Bureau of Entomology and Plant Quarantine. https://archive.org/stream/idaluses00unit/idaluses00unit_djvu.txt1
- Ministry of Health Resolution No. 549/2026. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/resoluci%C3%B3n-549-2026-425443/texto1
- Ministry of Health Resolution No. 549/2026. boletinoficial.gob.ar (n.d.). https://www.boletinoficial.gob.ar/detalleAviso/primera/341513/202605041
- Tobacco and Vaping Products Act (S.C. 1997, c. 13); Nicotine Concentration in Vaping Products Regulations (SOR/2021-123). laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/T-11.5/FullText.html1
- Tobacco and Vaping Products Act (S.C. 1997, c. 13); Nicotine Concentration in Vaping Products Regulations (SOR/2021-123). laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/regulations/SOR-2021-123/FullText.html1
- Tobacco and Vaping Products Act (S.C. 1997, c. 13); Nicotine Concentration in Vaping Products Regulations (SOR/2021-123). canada.ca (n.d.). https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/revisions-nicotine-buccal-pouches.html1
- Law No. 2354 of 2024. secretariasenado.gov.co (n.d.). https://www.secretariasenado.gov.co/senado/basedoc/ley_2354_2024.html1
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass review
A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Nicotine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.